25 reports

Abstract: - Global Interferon Market to Reach $9.1 Billion by 2027 - Amid the COVID-19 crisis, the global market for Interferon estimated at US$6.9 Billion in the year 2020, is projected to reach a revised size of US$9.1 Billion by 2027, growing at a CAGR of 3.9% over the period 2020-2027. - The U.S. Market is...

  • Interferon
  • World
  • China
  • United States

Abstract: - Global Beta Interferon Market to Reach $3.7 Billion by 2027 - Amid the COVID-19 crisis, the global market for Beta Interferon estimated at US$3.1 Billion in the year 2020, is projected to reach a revised size of US$3.7 Billion by 2027, growing at a CAGR of 2.6% over the period 2020-2027. - The U.S....

  • Interferon
  • World
  • China
  • United States

Major players in the interferons market are Roche, Merck, Bristol-Myers Squibb, Biogen Inc, Bayer AG, Zydus Cadila, Novartis AG, Pfizer Inc, Biosidus, and Nanoge. The global interferons market is expected to grow from $7.46 billion in 2020 to $7.61 billion in 2021 at a compound annual growth rate (CAGR) of 2%. The change in growth trend...

  • Interferon
  • World
  • Biologics Patents Registrations

Interferon Gamma (Immune Interferon or IFNG) - Drugs in Development, 2021 Summary Interferon Gamma (Immune Interferon or IFNG) - Drugs in Development, 2021 provides in depth analysis on Interferon Gamma (Immune Interferon or IFNG) targeted pipeline therapeutics. The report provides comprehensive...

  • Interferon
  • World

Interferon Beta (Fibroblast Interferon or IFNB or IFNB1) - Drugs in Development, 2021 Summary Interferon Beta (Fibroblast Interferon or IFNB or IFNB1) - Drugs in Development, 2021 provides in depth analysis on Interferon Beta (Fibroblast Interferon or IFNB or IFNB1) targeted pipeline therapeutics....

  • Interferon
  • Cell Therapy
  • Research And Development
  • Drug Development
  • World

Interferon Alpha/Beta Receptor 2 (Interferon Alpha Binding Protein or Type I Interferon Receptor 2 or IFNAR2) - Drugs in Development, 2021 Summary Interferon Alpha/Beta Receptor 2 (Interferon Alpha Binding Protein or Type I Interferon Receptor 2 or IFNAR2) - Drugs in Development, 2021 provides in...

  • Interferon
  • Biopharmaceutical
  • World

Interferon Alpha (IFNA) - Drugs in Development, 2021 Summary Interferon Alpha (IFNA) - Drugs in Development, 2021 provides in depth analysis on Interferon Alpha (IFNA) targeted pipeline therapeutics. The report provides comprehensive information complete with Analysis by Indications, Stage of Development,...

  • Interferon
  • Biopharmaceutical
  • World

Stimulator Of Interferon Genes Protein (Endoplasmic Reticulum Interferon Stimulator or Mediator Of IRF3 Activation or Transmembrane Protein 173 or STING or TMEM173) - Drugs in Development, 2021 Summary Stimulator Of Interferon Genes Protein (Endoplasmic Reticulum Interferon Stimulator or Mediator...

  • Interferon
  • World

About this market Interferons belong to the family of cytokines, a group of small proteins essential in cell signaling. They are synthesized and delivered by host cells in response to a pathogen’s harmful activities. They are generally used for treating immune system-related diseases such as cancer, hepatitis, ADS, multiple...

  • Interferon
  • Neurological Disorder
  • Therapy
  • World

Interferon Gamma Receptor 1 (CDw119 or CD119 or IFNGR1) - Drugs in Development, 2021 Summary Interferon Gamma Receptor 1 (CDw119 or CD119 or IFNGR1) - Drugs in Development, 2021 provides in depth analysis on Interferon Gamma Receptor 1 (CDw119 or CD119 or IFNGR1) targeted pipeline therapeutics. The...

  • Interferon
  • Research And Development
  • Drug Development
  • World

Interferon Alpha/Beta Receptor 1 (Cytokine Receptor Class II Member 1 or Cytokine Receptor Family 2 Member 1 or Type I Interferon Receptor 1 or IFNAR1) - Drugs in Development, 2021 Summary Interferon Alpha/Beta Receptor 1 (Cytokine Receptor Class II Member 1 or Cytokine Receptor Family 2 Member 1...

  • Protein Therapy
  • Interferon
  • Biopharmaceutical
  • World

Abstract: - Global Tuberculosis Testing Market to Reach $2.8 Billion by 2027 - Amid the COVID-19 crisis, the global market for Tuberculosis Testing estimated at US$2.4 Billion in the year 2020, is projected to reach a revised size of US$2.8 Billion by 2027, growing at a CAGR of 2.5% over the analysis period 2020-2027....

  • Interferon
  • Respiratory Diagnostic Device
  • World
  • China
  • United States

Abstract: - Global Growth Factors (Blood and Tissue) Market to Reach $66.9 Billion by 2027 - Amid the COVID-19 crisis, the global market for Growth Factors (Blood and Tissue) estimated at US$42.6 Billion in the year 2020, is projected to reach a revised size of US$66.9 Billion by 2027, growing at a CAGR of 6.7% over...

  • Colony Stimulating Factor
  • Interferon
  • World
  • China
  • United States

Interferon is mainly used for the treatment of hepatitis B, hepatitis C, multiple sclerosis, condyloma acuminatum and other diseases. Wherein, IFN-? is mainly suitable for curing hepatitis B and hepatitis C, while IFN-? is the mainstream medicine for MS which sees a higher incidence in Europe and America than in Asia, so foreign countries...

  • Interferon
  • China

Interferon Alpha (IFNA) Overview

  • Biopharmaceutical
  • Interferon
  • World
  • Drug Approval

Winners and losers: How well is your MS medical affairs team doing? Which MS drugs are benefiting from the best performing and most supportive medical affairs teams according to the doctors on the receiving end? According to this latest survey, satisfaction levels...

  • Interferon
  • Health Care Provider
  • Monoclonal Antibody
  • Spain
  • France
  • Germany
  • Italy
  • United Kingdom

Winners and losers: How well is your MS medical affairs team doing? Which MS drugs are benefiting from the best performing and most supportive medical affairs teams according to the doctors on the receiving end? According to this latest survey, satisfaction...

  • Interferon
  • Monoclonal Antibody
  • Health Care Provider
  • United States

Fore Pharma has released its new research, Interferon Alfa-2B Sales, Price Analysis, & Sales Forecast – 2017. Find out the sales of Interferon Alfa-2B worldwide and by countries in North America, Europe, Japan, BRIC, and Australia. Discover the growth trends of Interferon Alfa-2B by countries, and also find out sales forecast...

  • Interferon
  • World
  • Australia
  • Japan

Fore Pharma has released its new research, Interferon Beta-1A Sales, Price Analysis, & Sales Forecast – 2017. Find out the sales of Interferon Beta-1A worldwide and by countries in North America, Europe, Japan, BRIC, and Australia. Discover the growth trends of Interferon Beta-1A by countries, and also find out sales forecast...

  • Interferon
  • World
  • Australia
  • Japan

Fore Pharma has released its new research, Interferon Beta-1B Sales, Price Analysis, & Sales Forecast – 2017. Find out the sales of Interferon Beta-1B worldwide and by countries in North America, Europe, Japan, BRIC, and Australia. Discover the growth trends of Interferon Beta-1B by countries, and also find out sales forecast...

  • Interferon
  • World
  • Australia
  • Japan

Fore Pharma has released its new research, Interferon Gamma-1B Sales, Price Analysis, & Sales Forecast – 2017. Find out the sales of Interferon Gamma-1B worldwide and by countries in North America, Europe, Japan, BRIC, and Australia. Discover the growth trends of Interferon Gamma-1B by countries, and also find out sales forecast...

  • Interferon
  • World
  • Australia
  • Japan

MS medical affairs: oral therapies outperforming in the US. How does your team measure up? In the US multiple sclerosis (MS) market, medical affairs teams for oral therapies outperform their platform-therapy counterparts—earning 3 of the top 4 scores for overall...

  • Interferon
  • Neurological Disorder
  • Clinical Trial
  • Patient Data Management
  • Monoclonal Antibody
  • United States

MS medical affairs: oral therapies outperforming in Europe. How does your team measure up? In Europe’s Multiple Sclerosis (MS) market, medical affairs teams for oral therapies outperform their platform-therapy counterparts—earning the 3 highest scores for overall...

  • Interferon
  • Neurological Disorder
  • Clinical Trial
  • Patient Data Management
  • Monoclonal Antibody
  • Europe

Deal Report: Amarillo Biosciences terminates agreement with Cyto Biotech for low dose oral Interferon

  • Pharmaceutical
  • Interferon
  • World
  • Colorado
  • Dates Price
  • Drug Approval

Interferons are small, low molecular weight proteins of varying sizes induced during attack by infectious agents like viruses. Investigators have found that they are highly variable in nature and have several subtypes due to which misunderstanding is easily created. Furthermore, they have synergistic effect in which interferons belonging...

  • Interferon
  • World